Effectiveness and Safety of Ipilimumab Therapy in Advanced Melanoma: Evidence From Clinical Practice Sites in the US

Journal of Community and Supportive Oncology - United States
doi 10.12788/jcso.0124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontline Medical Communications, Inc.

Related search

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Pcn184 - Cost-Effectiveness of Nivolumab Plus Ipilimumab in Advanced Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Nivolumab in Combination With Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pcn2 - Effectiveness and Safety of Pembrolizumab in Advanced or Metastatic Melanoma: Preliminary Results From Real World

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Ipilimumab for the Treatment of Advanced Melanoma in Six Kidney Transplant Patients

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Hospitalization and Emergency Department Utilization in Patients With Advanced Melanoma Receiving Pembrolizumab vs. Ipilimumab Plus Nivolumab in US Academic Centers

Journal of Medical Economics
Health Policy
2019English

CPC-078 Ipilimumab for Advanced Melanoma: Drug Use Review

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Effectiveness and Safety of Narlaprevir in Real Clinical Practice of Chronic Hepatitis C

Jurnal Infektologii
Infectious Diseases
2019English

Outcomes by Line of Therapy and Programmed Death Ligand 1 Expression in Patients With Advanced Melanoma Treated With Pembrolizumab or Ipilimumab in KEYNOTE-006: A Randomised Clinical Trial

European Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy